← Browse by Condition
Medical Condition

advanced solid malignancies

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07368478 Phase 1
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

Enrollment
180 pts
Location
China
Sponsor
Biocity Biopharmaceutics Co., ...
View Trial →